Sign up
Quantellect · Congress · Trade Detail
NYSE: PFEPfizer Inc
RepublicanSenate

John Boozman sold Pfizer Inc (NYSE: PFE)

John Boozman (R-AR), a U.S. Senator, has disclosed 5 trades in Pfizer Inc (PFE) since 2015, 2 purchases and 3 sales, worth an estimated $40K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).

The trade highlighted here is a sale: John Boozman sold $1,001 - $15,000 of Pfizer Inc (NYSE: PFE) on December 21, 2018. Since that trade, PFE is down -9.98% against the S&P 500 up +237.91%, an outperformance of -247.89%.

Across these filings, John Boozman has been a net seller of PFE (a buy-to-sell ratio of 0.67). The most recent disclosed PFE transaction shown was dated February 13, 2025. Each row in the table below links to that trade and its post-trade performance versus the market.

Data updated

PFE trades
5
Disclosed Vol
$40K
Buys
2
40%
Sells
3
60%
Buy / Sell
0.67
ratio
First → Last
2015–2025

John Boozman's PFE trades vs the price

PFE is down -9.98% since John Boozman sold on December 21, 2018, versus +237.91% for the S&P 500.

Performance since this trade

Price change since trade
-9.98%
S&P 500 change since trade
+237.91%
Outperformance vs S&P 500
-247.89%

All John Boozman PFE trades

TradedTypeSizeReturnEst. profit
February 13, 2025SELL$23.52+6.95%
December 20, 2023BUY$23.49+7.05%-$718
January 22, 2021SELL$27.71-9.24%
December 21, 2018SELL$27.94-9.98%
April 24, 2015BUY$20.54+22.47%-$2K

Estimated profit is shown for buys only, marked to the latest close. It is an estimate and does not net later sells, taxes, or fees.

John Boozman & PFE trading FAQ

Is it legal for John Boozman to trade Pfizer Inc (PFE) stock?

Yes. Members of Congress are allowed to trade individual stocks, including Pfizer Inc (PFE), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.

When did John Boozman sell PFE?

John Boozman disclosed a sale of $1,001 - $15,000 of Pfizer Inc (PFE) on December 21, 2018, according to public STOCK Act filings.

How has PFE performed since John Boozman's trade?

Since John Boozman sold PFE on December 21, 2018, the stock is down -9.98%, versus +237.91% for the S&P 500 over the same period, an outperformance of -247.89%.

How many times has John Boozman traded PFE?

John Boozman has disclosed 5 PFE trades since 2015 (2 purchases and 3 sales). Every disclosed trade is listed on this page.

How soon must members of Congress disclose a trade?

Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.

Where can I see all congressional PFE trades?

Quantellect tracks every disclosed congressional trade in Pfizer Inc (PFE) on the Pfizer Inc congressional trading page, which aggregates filings across all members of Congress.

John Boozman's PFE tradesAll congressional filings for Pfizer IncJohn Boozman's full profile

Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.